Advertisement

Basic Strategies in Sentinel Node Detection and Exclusion or Verification of Cancer Metastasis into the Regional Node(s)

Keywords

Sentinel Node Sentinel Lymph Node Biopsy Merkel Cell Carcinoma Sentinel Lymph Node Dissection Sentinel Node Detection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alazraki NP, Eshima D, Eshima LA, Herda St, Murray DR, Vansant JP, Taylor AT (1997) Lymph scintigraphy, the sentinel node concept and the intraoperative gamma probe in melanoma, breast cancer and other potential cancers. Semin Nucl Med 27:55–68PubMedGoogle Scholar
  2. Albertini JJ, Cruse CW, Rapaport D, Wells K, Ross M, De-Conti R, Berman CG, Jared K, Messina J, Lyman G, Glass F, Fenske N, Reintgen DS (1996a) Intraoperative radio-lymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 223:217–224Google Scholar
  3. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen DS (1996b) Lymphatic mapping and sentinel node biopsy in the patients with breast cancer. JAMA 276:1818–1822CrossRefPubMedGoogle Scholar
  4. Alcand KM, Healy C, Colonje E, O'Doherty M, Nunan T, Page C, Higgins E, Russell-Jones R (2001) Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma. J Clin Oncol 15; 19(10):2674–2678PubMedGoogle Scholar
  5. Alex JC, Krag DN (1993) Gamma-probe guided localization of lymph-nodes. Surg Oncol 2:137–143PubMedGoogle Scholar
  6. Alex JC, Weaver DL, Fairbank JT, Rankin BS, Krag, DN (1993) Gamma-probe-guided lymph node localization in malignant melanoma. Surg Oncol 2:303–308CrossRefPubMedGoogle Scholar
  7. Altmannsberger M, Osborn M, Schauer A, Weber K (1981) Antibodies to different intermediate filament proteins cell type specific markers on paraffin embedded human tissues. Lab Invest 45:427–434PubMedGoogle Scholar
  8. Altmannsberger M, Osborn M, Weber K, Schauer A (1982) Expression of intermediate filaments in different epithelial and mesenchymal tumors. Pathol Res Pract 175:227–237PubMedGoogle Scholar
  9. Baisden BL, Askin FB, Lange JR, Westra WH (2000) HMB-45 immunohistochemical staining of sentinel lymph-nodes: a specific method for enhancing detection of micrometastases in patients with melanoma. Am J Surg Pathol 24(8):1140–1146CrossRefPubMedGoogle Scholar
  10. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Flemming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thomson JF (2001) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635–3648Google Scholar
  11. Bedrosian I, Faries MB, Guerry D 4th, Elenitsas R, Schuchter L, Mick R, Spitz FR, Bucky LP, Alavi A, Elder DE, Fraker DL, Czerniecki BJ (2000) Incidence of sentinel node metastasis in patients with thin primary melanoma (mm) with vertical growth phase. Ann Surg Oncol 7(4):262–267CrossRefPubMedGoogle Scholar
  12. Blaheta JH, Schittek B, Breuninger H, Garbe C (2001) Detection of micrometastasis in sentinel lymph node of patients with primary cutaneous melanoma. Recent Results Cancer Res 158:137–146PubMedGoogle Scholar
  13. Blocklet D, Donckier V, Vereecken P, Van Geertruyden J, Laporte M, Goldman S (2001) Nondetection of sentinel lymph node with lymphoscintigraphy as a result of massive malignant invasion shown by positron emission tomography. Clin Nucl Med 26(12):1013–1015CrossRefPubMedGoogle Scholar
  14. Boolbol SK, Fey JV, Borgen PI, Heerdt AS, Montgomery LL, Paglia M, Petrek JA, Cody HS 3rd, Van Zee KJ (2001) Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma. Ann Surg Oncol 8(1):20–24PubMedGoogle Scholar
  15. Borg A, Baldetorp B, Fernö M, Killander D, Olsson H, Sigurdsson H (1991) ErbB2 amplification in breast cancer with high rate of proliferation. Oncogene 6:137–143PubMedGoogle Scholar
  16. Borgstein PJ, Pijpers R, Comans EF, Diest PJ van, Boom RP, Meijer S (1998) Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 186:275–283CrossRefPubMedGoogle Scholar
  17. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F (1998) Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 351:793–796CrossRefPubMedGoogle Scholar
  18. Cascinelli N, Belli F, Santinami M, Fait V, Testori A, Ruka W, Cavaliere R, Moziillo N, Rossi CR, MacKie RM, Nieweg O, Pace M, Kirov K (2000) Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 7(6):469–474CrossRefPubMedGoogle Scholar
  19. Chung MH, Ye W, Giuliano AD (2001) Role for sentinel lymph node dissection in the management of large (> or =5 cm) invasive breast cancer. Ann Surg Oncol 8(9):688–692PubMedGoogle Scholar
  20. Clary BM, Brady MS, Lewis JJ, Coit DG (2001) Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg 233(2):250–258CrossRefPubMedGoogle Scholar
  21. Cochran AJ, Balda BR, Starz H, Bachter D, Krag DN, Cruse CW, Pijpers R, Morton DL (2000) The Augsburg Consensus. Techniques of lymphatic mapping sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer 15; 89(2):236–241CrossRefPubMedGoogle Scholar
  22. Cody HS 3rd, Fey J, Akhurst T, Fazzari M, Mazumdar M, Yeung H, Yeh SD, Borgen PI (2001) Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol 8(1):13–19CrossRefPubMedGoogle Scholar
  23. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, Ku NN, Lyman GH, Berman C, Haddad F, Reintgen DS (1998) Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227:645–651CrossRefPubMedGoogle Scholar
  24. Dixon M (1998) Sentinel node biopsy in breast cancer. Brit Med J 317:295–296PubMedGoogle Scholar
  25. Eggermont AM, Keilholz U, Testori A, Cook M, Lienard D, Ruiter DJ (2001) The EORTC melanoma group translational research program on prognostic factors and ultra-staging in association with the adjuvant therapy trials in stage II and stage III melanoma. European Organization for Research and Treatment of Cancer. Ann Surg Oncol 8[Suppl]:38S–40SPubMedGoogle Scholar
  26. Gershenwald JE, Mansfield PF, Lee JE, Ross MI (2000) Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (>04=4 mm) primary melanoma. Ann Surg Oncol 7(2):160–165CrossRefPubMedGoogle Scholar
  27. Gesuelli GC, Sartelli M, Berbellini A, Brianzoni E, Simonacci M, Sigona M (2000) Sentinel lymph node identification in the staging of cutaneous melanoma. Blue dye vs. radioguided localization. Minerva Chir 55(8–8):513–516PubMedGoogle Scholar
  28. Giuliano AE, Barth AM, Spivack B, Beitsch PD, Evans SW (1996) Incidence and predictors of axillary metastasis in T1 carcinoma of the breast. J Am Coll Surg 183(3):185–189PubMedGoogle Scholar
  29. Glass EC, Essner R, Morton DL (1998) Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma. J Nucl Med 39:1185–1190PubMedGoogle Scholar
  30. Gulec et al. (1997) Gamma probe guided sentinel node biopsy in breast cancer. Q J Nucl Med 41:251–261PubMedGoogle Scholar
  31. Harlow SP, Krag DN, Ashikaga T, Weaver DL, Meijer SJ, Loggie BW, Tanabe KK, Whitworth P Jr, Kuhn J, Kusminsky R, Carp NZ, Gadd M, Rawlings M Jr, Slingluff CL Jr (2001) Gamma probe guided biopsy of the sentinel node in malignant melanoma: a multicentre study. Melanoma Res 11(19):45–55CrossRefPubMedGoogle Scholar
  32. Högemann D, Josephson L, Weissleder R, Basilion JP (2000) Improvement of MRI-probes to allow efficient detection of gene expression. Bioconjug Chem 11(6):941–946CrossRefPubMedGoogle Scholar
  33. Joseph E, Brobeil A, Glass F, Glass J, Messina J, DeConti R, Cruse CW, Rapaport DP, Berman C, Fenske N, Reintgen SD (1998). Results of complete lymph node dissection in 83 melanoma patients with positive SLN. Ann Surg Oncol 5:119–125PubMedGoogle Scholar
  34. Kapteijn BAE, Nieweg OE, Mooi WJ, Balm AJ, Müller SH, Peterse JL, Valdes-Olmos RA, Hoefnagel CA, Kroon BB (1997a) Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye. Ann Surg Oncol 4:156–160PubMedGoogle Scholar
  35. Kapteijn BAE, Nieweg OE, Müller SH, Liem IH, Hoefnagel CA, Rütgers EJT, Kroon BBR (1997b) Validation of gamma probe detection of the sentinel node in melanoma. J Nucl Med 38:362–366PubMedGoogle Scholar
  36. Klimberg VS, Rubio IT, Henry R, Cowan C, Colvert M, Korourian S (1999) Subareolar versus peritumoral injection for location of the sentinel lymph node. Ann Surg 229(6):860–864; 864–865CrossRefPubMedGoogle Scholar
  37. Krag D, Harlow S, Weaver D, Ashikaga T (1998a) Technique of sentinel node resection in melanoma and breast cancer: probe guided surgery and lymphatic mapping. Eur J Surg Oncol 24:89–93CrossRefPubMedGoogle Scholar
  38. Krag DN, Ashikaga T, Harlow SP, Weaver DL (1998b) Development of sentinel node targeting technique in breast cancer patients. Breast 4:67–74CrossRefGoogle Scholar
  39. Krag DN, Weaver DL, Alex JC, Fairband JT (1993) Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335–339CrossRefGoogle Scholar
  40. Leong SPL, Steinmetz I, Habib FA, McMillan A, Gans JZ, Allen RE Jr, Morita E, El-Kadi M, Epstein HD, Kashani-Sabet M, Sagebiel RW (1998) Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg 132:666–673Google Scholar
  41. Linehan DC, Hill AD, Akhurst T, Yeung H, Yeh SD, Tran KN, Borgen PI, Cody HS 3rd (1999) Intradermal radio-colloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol 6(5):450–454CrossRefPubMedGoogle Scholar
  42. Marx D, Schauer A, Reiche C, May A, Ummenhofer L, Reles A, Rauschecker HF, Sauer R, Schumacher M (1990) c-erbB2-expression in correlation to other biological parameters of breast cancer. J Cancer Res Clin Oncol 116:15–20PubMedGoogle Scholar
  43. McCarter MD, Yeung H, Fey J, Borgen PI, Cody HS 3rd (2001) The breast cancer patient with multiple sentinel nodes: when to stop? J Am Coll Surg 192(6):692–697CrossRefPubMedGoogle Scholar
  44. McMasters KM, Wong SL, Edwards MJ, Ross MI, Chao C, Noyes RD, Viar V, Cerrito PB, Reintgen DS (2001a) Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. Surgery 130(2):151–156CrossRefPubMedGoogle Scholar
  45. McMasters KM, Wong SL, Martin RC 2nd, Chao C, Tuttle TM, Noyes RD, Carlson DJ, Laidley AL, McGlothin TQ, Ley PB, Brown CM, Glaser RL, Pennington RE, Turk PS, Simpson D, Cerrito PB, Edwards MJ; University of Louisville Breast Cancer Study Group (2001b) Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg 233(5):676–687CrossRefPubMedGoogle Scholar
  46. McMasters KM, Reintgen DS, Ross MI, Wong SL, Gershenwald JE, Krag DN, Noyes RD, Viar V, Cerrito PB, Edwards MJ (2001c) Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol 8(3):192–197PubMedGoogle Scholar
  47. Medina-Franco H, Beenken SW, Heslin MJ, Urist MM (2001) Sentinel node biopsy for cutaneous melanoma in the head and neck. Ann Surg Oncol 8(9):716–719PubMedGoogle Scholar
  48. Meijer S, Collet GJ, Pijpers HJ, Hattum L van, Hoekstra OS (1996) Less axillary dissection necessary due to sentinel node biopsy in patients with breast carcinoma. Ned Tijdschr Geneeskd 9; 140(45):2239–2243PubMedGoogle Scholar
  49. Miltenburg DM, Miller C, Karamlou TB, Brunicardi FC (1999) Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res 15; 84(2):138–142CrossRefPubMedGoogle Scholar
  50. Miner TJ, Shriver CD, Flicek PR, Miner FC, Jaques DP, Maniscalco-Theberge ME, Krag DN (1999) Guidelines for the safe use of radioactive materials during localization and resection of the sentinel lymph node. Ann Surg Oncol 6:75–82CrossRefPubMedGoogle Scholar
  51. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ, Cochran AJ (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392–399PubMedGoogle Scholar
  52. Müller MG, Borgstein PJ, Pijpers R, Leeuwen PA van, Diest PJ van, Gupta A, Meijer S (2000) Reliability of the sentinel node procedure in melanoma patients: analysis of failures after long-term follow-up. Ann Surg Oncol 7(6):461–468PubMedGoogle Scholar
  53. Müller MG, Leeuwen PA van, Diest PJ van, Vuylsteke RJ, Pijpers R, Meijer S (2001) No indication for performing sentinel node biopsy in melanoma patients with a Breslow thickness of less than 0.9 mm. Melanoma Res 11(3):303–307CrossRefPubMedGoogle Scholar
  54. Murray DR, Carlson GW, Greenlee R, Alazraki N, Fry-Spray C, Hestley A, Poole R, Blais M, Timbert DS, Vansant J (2000) Surgical management of malignant melanoma using dynamic lymphoscintigraphy and gamma probe-guided sentinel lymph node biopsy: the Emory experience. Am Surg 66(8):763–767PubMedGoogle Scholar
  55. Nieweg OE, Kapteijn BA, Peterse JL, Rutgers EJ, Dongen JA van, Kroon BB (1996) Identification of the sentinel node in patients with breast carcinoma. Ned Tijdschr Geneeskd [9] 140(45):2235–2239PubMedGoogle Scholar
  56. Noguchi M, Motomura K, Imoto S, Miyauchi M, Sato K, Iwata H, Ohta M, Kurosumi M, Tsugawa K (2000) A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society. Breast Cancer Res Treat 63(1):31–40CrossRefPubMedGoogle Scholar
  57. Paganelli G, Cicco C, Cremonesi M, Prisco G, Calza P, Luini A, Zucali P, Veronesi U (1998) Optimised sentinel node scintigraphy in breast cancer. Q J Nucl Med 42:49–53PubMedGoogle Scholar
  58. Pellegrino D, Bellina CR, Manca G, Boni G, Grosso M, Volterrani D, Desideri I, Bianchi F, Bottom A, Ciliberti V, Salimbeni G, Dandini D, Castagna M, Zucchi V, Romanini A, Bianchi R (2000) Detection of melanoma cells in peripheral blood and sentinel lymph-nodes by RT-PCR analysis: a comparative study with immunohistochemistry. Tumori 86(4):336–338PubMedGoogle Scholar
  59. Pijpers R, Borgstein PJ, Meijer S et al. (1997) Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance. World J Surg 21:788–793CrossRefPubMedGoogle Scholar
  60. Porter GA, Ross MI, Berman RS, Lee JE, Mansfield PF, Gershenwald JE (2000a) Significance of multiple nodal basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy. Ann Surg Oncol 7(4):256–261CrossRefPubMedGoogle Scholar
  61. Porter GA, Ross MI, Berman RS, Sumner WE 3rd, Lee JE, Mansfield PF, Gershenwald JE (2000b) How many lymph-nodes are enough during sentinel lymphadenectomy for primary melanoma? Surgery 128(2):306–311CrossRefPubMedGoogle Scholar
  62. Rasgon BM (2001) Use of low-dose technetium Tc99m sulfur colloid to locate sentinel lymph-nodes in melanoma of the head and neck: preliminary study. Laryngoscope 111(8):1366–1372CrossRefPubMedGoogle Scholar
  63. Reintgen D, Cruse CW, Wells K, Berman C, Fenske N, Glass F, Schroer K, Heller R, Ross M, Lyman G, Cox C, Rapaport D, Seigler HF, Balch C (1994) The orderly progression of melanoma nodal metastases. Ann Surg 220:759–767PubMedGoogle Scholar
  64. Rodrigues LK, Leong SP, Kashani-Sabet M, Wong JH (2001) Early experience with sentinel lymph node mapping for Merkel cell carcinoma. J Am Acad Dermatol 45(2):303–308CrossRefPubMedGoogle Scholar
  65. Roozendaal GK, Vries DJD de, Poll D van, Jansen L, Schraffordt Koops H, Nieweg OE, Kroon BB (2001) Sentinel nodes outside lymph node basins in patients with melanoma. Br J Surg 88(2):305–308CrossRefPubMedGoogle Scholar
  66. Rovere G della, Bird PA (1998) Sentinel-lympho-node in breast cancer. Lancet 352:421–422CrossRefPubMedGoogle Scholar
  67. Schauer A, Osborn M, Altmannsberger M, Weber K (1982) Expression of intermediate filaments in different human tumors. Jahrestagung der Gesellschaft für Histochemie, Gargellen-Montafon, congress volumeGoogle Scholar
  68. Schauer A, Marx D, Ummenhofer L, Rauschecker H, Gatzemeier W, Sauer R, Schumacher M, Sauerbrei W (1990) Die Multicenter Studie „Kleines Mammacarcinom. Vorläufige Ergebnisse — Neue Aspekte“. Dtsch Ärzteblatt 87:3628–3638Google Scholar
  69. Schauer A, Marx D, Lipp I, Schumacher M, Sauerbrei W, Rauschecker H, Sauer R (1992) Diagnostic tools and prognostic factors in human breast evaluated by morphological and immunohistochemical methods. In: Gogliotti L, Sapino A, Bussolati G (eds) Breast cancer: biological and clinical progress. Kluwer, Dordrecht, p 176Google Scholar
  70. Shidham VB, Qi DY, Acker S, Kampalath B, Chang CC, George V, Komorowski R (2001) Evaluation of micrometastases in sentinel lymph-nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45. Am J Surg Pathol 25(8):1039–1046CrossRefPubMedGoogle Scholar
  71. Shivers SC, Li W, Lin J, Stall A, Stafford M, Messina J, Glass LF, Reintgen DS (2001) The clinical relevance of molecular staging for melanoma. Recent Results Cancer Res 158:187–199PubMedGoogle Scholar
  72. Slingluff CL Jr, Stidham KR, Ricci WM, Stanley WE, Seigler HF (1994) Surgical management of regional lymph-nodes in patients with melanoma. Experience with 4,682 patients. Ann Surg 219:120–130PubMedGoogle Scholar
  73. Smith LF, Cross MJ, Klimberg VS (2000) Subareolar injection is a better technique for sentinel lymph node biopsy. Ann J Surg 180(6):434–437CrossRefGoogle Scholar
  74. Statius Muller MG, Leeuwen PA van, Lange-De Klerk ES de, Diest PJ van, Pijpers R, Ferwerda CC, Vuylsteke RJ, Meijer S (2001) The sentinel lymph node status is an important factor for predicting clinical outcome in patients with State I or II cutaneous melanoma. Cancer 15; 91(12):2401–2408PubMedGoogle Scholar
  75. Sugranes G, Vidal-Sicart S, Piulachs J, Bombuy E, Pons F, Castel T, Rull R, Herranz R, Visa J (2001) Gamma-detecting probe used intraoperatively to locate the sentinel lymph node in patients with malignant melanoma. Eur J Surg 167(8):581–586CrossRefPubMedGoogle Scholar
  76. Temple CL, Scilley CG, Engel CJ, Shum DT, Lohmann RC, Mattar AG, Zabel PL (2000) Sentinel node biopsy in melanoma using technetium-99m rhenium colloid: the London experience. Ann Plast Surg 45(5):491–499PubMedGoogle Scholar
  77. Thelmo MC, Morita ET, Treseler PA, Ngyuen LH, Allen RE Jr, Sagebiel RW, Kashani-Sabet M, Leong SP (2001) Micrometastasis to in-transit lymph-nodes from extremity and truncal malignant melanoma. Ann Surg Oncol 8(5):444–448PubMedGoogle Scholar
  78. Thompson JF (2001) The Sydney Melanoma Unit experience of sentinel lymphadenectomy for melanoma. Ann Surg Oncol 8[Suppl]:44S–47SPubMedGoogle Scholar
  79. Tsugawa K, Noguchi M, Miwa K, Bando E, Yokoyama K, Nakajima K, Michighishi T, Tonami N, Minato H, Nonomura A (2000) Dye-and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin. Breast Cancer 7(1):87–94PubMedGoogle Scholar
  80. Turner RR, Ollila DW, Krasne DL, Giuliano AE (1997) Histopathological validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 226:271–278CrossRefPubMedGoogle Scholar
  81. Uren RF, Howman-Giles RB, Thompson JF, Malouf D, Ramsey-Stewart G, Niesche FW, Renwick SB (1995) Mammary lymphoscintigraphy in breast cancer. J Nucl Med 36(10):1775–1780PubMedGoogle Scholar
  82. Uren RF, Howman-Giles R, Thompson JF, McCarthy WH, Quinn MJ, Roberts JM, Shaw HM (2000) Interval nodes: the forgotten sentinel nodes in patients with melanoma. Arch Surg 135(10):1168–1172CrossRefPubMedGoogle Scholar
  83. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida ST, Bodeni N, Costa A, Cicco C, Geraghty JG, Luine A, Sacchini V, Veronesi P (1997) Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349:1864–1867CrossRefPubMedGoogle Scholar
  84. Villa G, Agnese G, Bianchi P, Buffoni F, Costa R, Carli F, Peressini A, Solari N, Cafiero F, Mariani G (2000) Mapping the sentinel lymph node in malignant melanoma by blue dye, lymphoscintigraphy and intraoperative gamma probe. Tumori 86(4):343–345PubMedGoogle Scholar
  85. Wagner JD, Corbett L, Park HM, Davidson D, Coleman JJ, Havlik RJ, Hayes JT 2nd (2000a) Sentinel lymph node biopsy for melanoma: experience with 234 consecutive procedures. Plast Reconstr Surg 105(6):1956–1966PubMedGoogle Scholar
  86. Wagner JD, Gordon MS, Chuang TY, Coleman JJ 3rd, Hayes JT, Jung SH, Love C (2000b) Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma. Cancer 15; 89(2):453–462CrossRefPubMedGoogle Scholar
  87. Weiss M, Konz B, Schmid-Wendtner MH, Sander C, Dresel S, Tatsch K, Volkenandt M, Hahn K (2000) Metastases in malignant melanoma despite histologically negative sentinel lymph node: should the concept be changed? Nuklearmedizin 39(7):214–217PubMedGoogle Scholar
  88. Wong SL, Chao C, Edwards MJ, Tuttle TM, Noyes RD, Carlson DJ, Laidley AL, McGlothin TQ, Ley PB, Brown CM, Glaser RL, Pennington RE, Turk PS, Simpson D, McMasters KM (2001a) Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers. Am Surg 67(6):522–526PubMedGoogle Scholar
  89. Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Carlson DJ, Cerrito PB, McMasters KM (2001b) Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Surg 192(6):684–649CrossRefGoogle Scholar
  90. Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Woo C, Cerrito PB, McMasters KM, University of Louisville Breast Cancer Sentinel Lymph Node Study Group (2001c) Predicting the status of the nonsentinel axillary nodes: a multicenter study. Arch Surg 136(5):563–568CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Personalised recommendations